These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 7288282

  • 21. [Direct conversion of ursodeoxycholic acid to chenodeoxycholic acid by human intestinal microorganisms under the anaerobic condition (author's transl)].
    Higashi S, Setoguchi T, Katsuki T.
    Nihon Shokakibyo Gakkai Zasshi; 1980 Jan; 77(1):113. PubMed ID: 7359762
    [No Abstract] [Full Text] [Related]

  • 22. Bile acid transformation by the intestinal flora and cholesterol saturation in bile. Effects of Streptococcus faecium administration.
    Salvioli G, Salati R, Bondi M, Fratalocchi A, Sala BM, Gibertini A.
    Digestion; 1982 Jan; 23(2):80-8. PubMed ID: 7095315
    [Abstract] [Full Text] [Related]

  • 23. Oral gavage of nano-encapsulated conjugated acrylic acid-bile acid formulation in type 1 diabetes altered pharmacological profile of bile acids, and improved glycaemia and suppressed inflammation.
    Mooranian A, Zamani N, Ionescu CM, Takechi R, Luna G, Mikov M, Goločorbin-Kon S, Kovačević B, Al-Salami H.
    Pharmacol Rep; 2020 Apr; 72(2):368-378. PubMed ID: 32048259
    [Abstract] [Full Text] [Related]

  • 24. Differing effects of ursodeoxycholic or chenodeoxycholic acid on biliary cholesterol saturation and bile acid metabolism in man. A dose-response study.
    Thistle JL, Larusso NF, Hofmann AF, Turcotte J, Carlson GL, Ott BJ.
    Dig Dis Sci; 1982 Feb; 27(2):161-8. PubMed ID: 7075411
    [Abstract] [Full Text] [Related]

  • 25. Enrichment of the more hydrophilic bile acid ursodeoxycholic acid in the fecal water-soluble fraction after feeding to rats with colon polyps.
    Batta AK, Salen G, Holubec H, Brasitus TA, Alberts D, Earnest DL.
    Cancer Res; 1998 Apr 15; 58(8):1684-7. PubMed ID: 9563483
    [Abstract] [Full Text] [Related]

  • 26. Effect of ursodeoxycholic acid and chenodeoxycholic acid on cholesterol and bile acid metabolism.
    Tint GS, Salen G, Shefer S.
    Gastroenterology; 1986 Oct 15; 91(4):1007-18. PubMed ID: 3527851
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Liquid crystal formation in ursodeoxycholate-rich human gallbladder bile.
    Igimi H, Asakawa S, Watanabe D, Shimura H.
    Gastroenterol Jpn; 1983 Apr 15; 18(2):93-7. PubMed ID: 6852442
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [The influence of chenodeoxycholic acid and ursodeoxycholic acid on the hepatic structure of the rat (author's transl)].
    Leuschner U, Schneider M, Korte L.
    Z Gastroenterol; 1979 Apr 15; 17(4):244-55. PubMed ID: 433375
    [Abstract] [Full Text] [Related]

  • 33. Value of serum determinations for prediction of increased ursodeoxycholic and chenodeoxycholic levels in bile.
    Bazzoli F, Fromm H, Roda A, Tunuguntla AK, Roda E, Barbara L, Amin P.
    Dig Dis Sci; 1985 Jul 15; 30(7):650-4. PubMed ID: 4006647
    [Abstract] [Full Text] [Related]

  • 34. Epimerization of chenodeoxycholic acid to ursodeoxycholic acid by Clostridium baratii isolated from human feces.
    Lepercq P, Gérard P, Béguet F, Raibaud P, Grill JP, Relano P, Cayuela C, Juste C.
    FEMS Microbiol Lett; 2004 Jun 01; 235(1):65-72. PubMed ID: 15158263
    [Abstract] [Full Text] [Related]

  • 35. Thin-layer chromatographic separation of conjugates of ursodeoxycholic acid from those of litho-, chenodeoxy-, deoxy-, and cholic acids.
    Batta AK, Shefer S, Salen G.
    J Lipid Res; 1981 May 01; 22(4):712-4. PubMed ID: 7276746
    [Abstract] [Full Text] [Related]

  • 36. Hydrophilic but not hydrophobic bile acids prevent gallbladder muscle dysfunction in acute cholecystitis.
    Xiao ZL, Biancani P, Carey MC, Behar J.
    Hepatology; 2003 Jun 01; 37(6):1442-50. PubMed ID: 12774024
    [Abstract] [Full Text] [Related]

  • 37. Urinary and fecal keto bile acids in liver cirrhosis.
    Amuro Y, Endo T, Higashino K, Uchida K, Yamamura Y.
    Clin Chim Acta; 1981 Aug 10; 114(2-3):137-47. PubMed ID: 7285341
    [Abstract] [Full Text] [Related]

  • 38. Changes in bile acid composition and effect on cytolytic activity of fecal water by ursodeoxycholic acid administration: a placebo-controlled cross-over intervention trial in healthy volunteers.
    van Gorkom BA, van der Meer R, Boersma-van Ek W, Termont DS, de Vries EG, Kleibeuker JH.
    Scand J Gastroenterol; 2002 Aug 10; 37(8):965-71. PubMed ID: 12229974
    [Abstract] [Full Text] [Related]

  • 39. Long-Term Ursodeoxycholic Acid Therapy Does Not Alter Lithocholic Acid Levels in Patients with Cystic Fibrosis with Associated Liver Disease.
    Colombo C, Crosignani A, Alicandro G, Zhang W, Biffi A, Motta V, Corti F, Setchell KDR.
    J Pediatr; 2016 Oct 10; 177():59-65.e1. PubMed ID: 27297203
    [Abstract] [Full Text] [Related]

  • 40. Bile acid N-acetylglucosaminidation. In vivo and in vitro evidence for a selective conjugation reaction of 7 beta-hydroxylated bile acids in humans.
    Marschall HU, Matern H, Wietholtz H, Egestad B, Matern S, Sjövall J.
    J Clin Invest; 1992 Jun 10; 89(6):1981-7. PubMed ID: 1602004
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.